Cost-effectiveness of Universal BRCA1/2 Screening Evidence-Based Decision Making

被引：30
|
作者：
Long, Elisa F. [1 ]
Ganz, Patricia A. [2 ,3 ,4 ]
机构：
[1] Univ Calif Los Angeles, Anderson Sch Management, 110 Westwood Plaza,Ste B508, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Div Canc Prevent & Control Res, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA
来源：
JAMA ONCOLOGY | 2015年 / 1卷 / 09期
关键词：
MUTATION CARRIERS; MAMMOGRAPHY; POPULATION;
D O I：
10.1001/jamaoncol.2015.2340
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1217 / 1218
页数：2
相关论文
共 50 条
  • [21] Affordability and cost-effectiveness: Decision-making on the cost-effectiveness plane
    Sendi, PP
    Briggs, AH
    HEALTH ECONOMICS, 2001, 10 (07) : 675 - 680
  • [22] Cost-Effectiveness of Adjuvant Olaparib for Patients With Breast Cancer and Germline BRCA1/2 Mutations
    Zettler, Christina M.
    De Silva, Dilanka L.
    Blinder, Victoria S.
    Robson, Mark E.
    Elkin, Elena B.
    JAMA NETWORK OPEN, 2024, 7 (01)
  • [23] Cost-effectiveness of breast magnetic resonance imaging to screen BRCA1/2 mutation carriers
    Crystal, Pavel
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (22): : 2681 - 2682
  • [24] Evidence-based medicine meets cost-effectiveness analysis
    Clancy, CM
    Kamerow, DB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (04): : 329 - 330
  • [25] Cost-Effectiveness Analysis: A Component of Evidence-Based Education
    Detrich, Ronnie
    SCHOOL PSYCHOLOGY REVIEW, 2020, 49 (04) : 423 - 430
  • [26] Complex decision-making for BRCA1/2 carriers
    Matloff, ET
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (05): : 266 - 268
  • [27] COST-EFFECTIVENESS OF UNIVERSAL HEPATITIS B IMMUNIZATION IN VIETNAM: APPLICATION OF COST-EFFECTIVENESS AFFORDABILITY CURVES IN HEALTH DECISION-MAKING
    Tu, H. A. T.
    de Vries, R.
    Woerdenbag, H. J.
    van Hulst, M.
    Postma, M. J.
    VALUE IN HEALTH, 2010, 13 (07) : A250 - A250
  • [28] Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial
    Kautz-Freimuth, Sibylle
    Redaelli, Marcus
    Shukri, Arim
    Kentenich, Hannah
    Simic, Dusan
    Mildenberger, Vanessa
    Schmutzler, Rita
    Rhiem, Kerstin
    Stock, Stephanie
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2023, 23 (01)
  • [29] Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial
    Sibylle Kautz-Freimuth
    Marcus Redaèlli
    Arim Shukri
    Hannah Kentenich
    Dusan Simic
    Vanessa Mildenberger
    Rita Schmutzler
    Kerstin Rhiem
    Stephanie Stock
    BMC Medical Informatics and Decision Making, 23
  • [30] Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis
    Phi, Xuan-Anh
    Greuter, Marcel J. W.
    Obdeijn, Inge-Marie
    Oosterwijk, Jan C.
    Feenstra, Talitha L.
    Houssami, Nehmat
    de Bock, Geertruida H.
    BREAST, 2019, 45 : 82 - 88
12345